A high level of CSF-1 or CSF-1R expression in the tumor or peri-tumor tissue has been associated with poor patient survival in lymphoma, breast cancer, and hepatocellular carcinoma [83,84,85,86]. This evidence concerns the gene CSF1R and breast carcinoma.